These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 24662842

  • 1. Lubiprostone (Amitiza) for opioid-induced constipation.
    Med Lett Drugs Ther; 2013 Jun 10; 55(1418):47-8. PubMed ID: 24662842
    [No Abstract] [Full Text] [Related]

  • 2. Lubiprostone (Amitiza) for irritable bowel syndrome with constipation.
    Med Lett Drugs Ther; 2008 Jul 14; 50(1290):53-4. PubMed ID: 18617872
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lubiprostone for chronic constipation in adults.
    Drug Ther Bull; 2014 Apr 14; 52(4):42-4. PubMed ID: 24722574
    [Abstract] [Full Text] [Related]

  • 5. Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.
    Marciniak CM, Toledo S, Lee J, Jesselson M, Bateman J, Grover B, Tierny J.
    World J Gastroenterol; 2014 Nov 21; 20(43):16323-33. PubMed ID: 25473191
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lubiprostone for the treatment of opioid-induced bowel dysfunction.
    Wong BS, Camilleri M.
    Expert Opin Pharmacother; 2011 Apr 21; 12(6):983-90. PubMed ID: 21385112
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lubiprostone: chronic constipation and irritable bowel syndrome with constipation.
    Lacy BE, Chey WD.
    Expert Opin Pharmacother; 2009 Jan 21; 10(1):143-52. PubMed ID: 19236188
    [Abstract] [Full Text] [Related]

  • 13. Current and future therapies for chronic constipation.
    Tack J.
    Best Pract Res Clin Gastroenterol; 2011 Feb 21; 25(1):151-8. PubMed ID: 21382586
    [Abstract] [Full Text] [Related]

  • 14. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety.
    Johanson JF, Ueno R.
    Aliment Pharmacol Ther; 2007 Jun 01; 25(11):1351-61. PubMed ID: 17509103
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Management of constipation in Parkinson's disease.
    Rossi M, Merello M, Perez-Lloret S.
    Expert Opin Pharmacother; 2015 Mar 01; 16(4):547-57. PubMed ID: 25539892
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lubiprostone for the treatment of functional constipation in children.
    Hyman PE, Di Lorenzo C, Prestridge LL, Youssef NN, Ueno R.
    J Pediatr Gastroenterol Nutr; 2014 Mar 01; 58(3):283-91. PubMed ID: 24048162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.